Literature DB >> 15733719

Risk of oral infection with bovine spongiform encephalopathy agent in primates.

Corinne Ida Lasmézas1, Emmanuel Comoy, Stephen Hawkins, Christian Herzog, Franck Mouthon, Timm Konold, Frédéric Auvré, Evelyne Correia, Nathalie Lescoutra-Etchegaray, Nicole Salès, Gerald Wells, Paul Brown, Jean-Philippe Deslys.   

Abstract

The uncertain extent of human exposure to bovine spongiform encephalopathy (BSE)--which can lead to variant Creutzfeldt-Jakob disease (vCJD)--is compounded by incomplete knowledge about the efficiency of oral infection and the magnitude of any bovine-to-human biological barrier to transmission. We therefore investigated oral transmission of BSE to non-human primates. We gave two macaques a 5 g oral dose of brain homogenate from a BSE-infected cow. One macaque developed vCJD-like neurological disease 60 months after exposure, whereas the other remained free of disease at 76 months. On the basis of these findings and data from other studies, we made a preliminary estimate of the food exposure risk for man, which provides additional assurance that existing public health measures can prevent transmission of BSE to man.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15733719     DOI: 10.1016/S0140-6736(05)17985-9

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  32 in total

1.  Squirrel monkeys (Saimiri sciureus) infected with the agent of bovine spongiform encephalopathy develop tau pathology.

Authors:  P Piccardo; J Cervenak; O Yakovleva; L Gregori; K Pomeroy; A Cook; F S Muhammad; T Seuberlich; L Cervenakova; D M Asher
Journal:  J Comp Pathol       Date:  2011-10-20       Impact factor: 1.311

2.  Complex proteinopathy with accumulations of prion protein, hyperphosphorylated tau, α-synuclein and ubiquitin in experimental bovine spongiform encephalopathy of monkeys.

Authors:  Pedro Piccardo; Juraj Cervenak; Ming Bu; Lindsay Miller; David M Asher
Journal:  J Gen Virol       Date:  2014-04-25       Impact factor: 3.891

3.  PrPTSE distribution in a primate model of variant, sporadic, and iatrogenic Creutzfeldt-Jakob disease.

Authors:  Christian Herzog; Julie Rivière; Nathalie Lescoutra-Etchegaray; Aurore Charbonnier; Virginie Leblanc; Nicole Salès; Jean-Philippe Deslys; Corinne Ida Lasmézas
Journal:  J Virol       Date:  2005-11       Impact factor: 5.103

4.  Bov-tA short interspersed nucleotide element sequences in circulating nucleic acids from sera of cattle with bovine spongiform encephalopathy (BSE) and sera of cattle exposed to BSE.

Authors:  Ekkehard Schütz; Howard B Urnovitz; Leonid Iakoubov; Walter Schulz-Schaeffer; Wilhelm Wemheuer; Bertram Brenig
Journal:  Clin Diagn Lab Immunol       Date:  2005-07

5.  Susceptibility of domestic cats to chronic wasting disease.

Authors:  Candace K Mathiason; Amy V Nalls; Davis M Seelig; Susan L Kraft; Kevin Carnes; Kelly R Anderson; Jeanette Hayes-Klug; Edward A Hoover
Journal:  J Virol       Date:  2012-12-12       Impact factor: 5.103

6.  Insights into Chronic Wasting Disease and Bovine Spongiform Encephalopathy Species Barriers by Use of Real-Time Conversion.

Authors:  Kristen A Davenport; Davin M Henderson; Jifeng Bian; Glenn C Telling; Candace K Mathiason; Edward A Hoover
Journal:  J Virol       Date:  2015-07-08       Impact factor: 5.103

7.  Preclinical deposition of pathological prion protein in muscle of experimentally infected primates.

Authors:  Susanne Krasemann; Melanie Neumann; Markus Geissen; Walter Bodemer; Franz-Josef Kaup; Walter Schulz-Schaeffer; Nathalie Morel; Adriano Aguzzi; Markus Glatzel
Journal:  PLoS One       Date:  2010-11-11       Impact factor: 3.240

8.  Assessment of the PrPc Amino-Terminal Domain in Prion Species Barriers.

Authors:  Kristen A Davenport; Davin M Henderson; Candace K Mathiason; Edward A Hoover
Journal:  J Virol       Date:  2016-11-14       Impact factor: 5.103

9.  Susceptibilities of nonhuman primates to chronic wasting disease.

Authors:  Brent Race; Kimberly D Meade-White; Michae W Miller; Kent D Barbian; Richard Rubenstein; Giuseppe LaFauci; Larisa Cervenakova; Cynthia Favara; Donald Gardner; Dan Long; Michael Parnell; James Striebel; Suzette A Priola; Anne Ward; Elizabeth S Williams; Richard Race; Bruce Chesebro
Journal:  Emerg Infect Dis       Date:  2009-09       Impact factor: 6.883

10.  Upregulation of miRNA hsa-miR-342-3p in experimental and idiopathic prion disease.

Authors:  Judith Montag; Reiner Hitt; Lennart Opitz; Walter J Schulz-Schaeffer; Gerhard Hunsmann; Dirk Motzkus
Journal:  Mol Neurodegener       Date:  2009-08-27       Impact factor: 14.195

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.